BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 61 filers reported holding BEAM THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $35,327,654 | -16.4% | 1,468,748 | +10.9% | 0.00% | -20.0% |
Q2 2023 | $42,280,918 | +14.8% | 1,324,175 | +10.1% | 0.01% | 0.0% |
Q1 2023 | $36,815,324 | +81546.7% | 1,202,329 | +4.3% | 0.01% | -16.7% |
Q4 2022 | $45,091 | -99.9% | 1,152,940 | +4.4% | 0.01% | -25.0% |
Q3 2022 | $52,617,000 | +40.5% | 1,104,475 | +14.2% | 0.01% | +60.0% |
Q2 2022 | $37,441,000 | -24.2% | 967,223 | +12.2% | 0.01% | -16.7% |
Q1 2022 | $49,375,000 | -27.0% | 861,694 | +1.5% | 0.01% | -25.0% |
Q4 2021 | $67,624,000 | -5.6% | 848,589 | +3.1% | 0.01% | -20.0% |
Q3 2021 | $71,600,000 | -18.8% | 822,894 | +20.1% | 0.01% | -16.7% |
Q2 2021 | $88,201,000 | +84.8% | 685,274 | +14.9% | 0.01% | +71.4% |
Q1 2021 | $47,736,000 | +10.1% | 596,405 | +12.3% | 0.01% | 0.0% |
Q4 2020 | $43,347,000 | +295.9% | 530,965 | +19.4% | 0.01% | +250.0% |
Q3 2020 | $10,948,000 | +85.7% | 444,690 | +111.2% | 0.00% | +100.0% |
Q2 2020 | $5,894,000 | +357.6% | 210,529 | +194.2% | 0.00% | – |
Q1 2020 | $1,288,000 | – | 71,566 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,362,635 | $189,105,000 | 91.90% |
PATHWAY CAPITAL MANAGEMENT, LP | 37,399 | $2,993,000 | 16.59% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,390 | $17,960,000 | 10.54% |
HSG Holding Ltd | 796,089 | $63,719,000 | 4.73% |
DC Investments Management, LLC | 21,010 | $1,682,000 | 4.17% |
Monashee Investment Management LLC | 268,820 | $21,516,000 | 3.31% |
Redmile Group, LLC | 2,532,523 | $202,703,000 | 2.86% |
HAMILTON LANE ADVISORS LLC | 98,761 | $7,905,000 | 2.58% |
Alphabet Inc. | 640,792 | $51,289,000 | 2.07% |
Casdin Capital, LLC | 818,820 | $65,538,000 | 1.95% |